Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Completed3
Recruiting3
Other1

Role Distribution

Principal Investigator7
PI Rate100%

Activity Timeline

Clinical Trials (7)

NCT06847282Recruiting
Motor Outcomes to Validate Evaluations in Pediatric FSHD (MOVE Peds)
Muscular Dystrophy, Facioscapulohumeral
PrincipalinvestigatorStart date: 2025-05-22
NCT06527222Phase 2Recruiting
A Study of Ranolazine in ALS
Amyotrophic Lateral Sclerosis
PrincipalinvestigatorStart date: 2025-04-29
NCT04635891Recruiting
Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD)
FSHD
PrincipalinvestigatorStart date: 2020-12-15
NCT03458832Active Not Recruiting
Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD
Facioscapulohumeral Muscular Dystrophy
PrincipalinvestigatorStart date: 2018-03-05
NCT02852278Completed
A Patient Centric Motor Neuron Disease Activities of Daily Living Scale
Amyotrophic Lateral SclerosisHereditary Spastic ParaplegiaPrimary Lateral Sclerosis+1 more
PrincipalinvestigatorStart date: 2016-12-01
NCT02766985Completed
Rasch-analysis of Clinical Severity in FSHD
Facioscapulohumeral Muscular Dystrophy
Principalinvestigator

Research Network

Collaboration Network

5 collaborators·7 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Callyn Kirk, MSPH

University of South Florida

Moderately Similar
1 trials

Shared therapeutic areas:

Amyotrophic Lateral SclerosisSpastic Paraplegia, HereditaryLateral Sclerosis+1 more

Worked with same sponsors:

National Institutes of Health (NIH)University of Kansas+2 more
Collaborated on 1 trial
Similarity Score44%

Michael Benatar, MD, PhD

University of Miami

Moderately Similar
2 trials

Shared therapeutic areas:

Amyotrophic Lateral SclerosisSpastic Paraplegia, HereditaryLateral Sclerosis+1 more

Worked with same sponsors:

National Institute of Neurological Disorders and Stroke (NINDS)National Institutes of Health (NIH)+3 more
Collaborated on 1 trial
Similarity Score44%

Jeffery Krischer, PhD

University of South Florida, Data Management Coordinating Center

Moderately Similar
1 trials

Shared therapeutic areas:

Amyotrophic Lateral SclerosisSpastic Paraplegia, HereditaryLateral Sclerosis+1 more

Worked with same sponsors:

National Institutes of Health (NIH)University of Kansas+2 more
Collaborated on 1 trial
Similarity Score44%

Rabi Tawil, MD

University of Rochester

Related
2 trials

Shared therapeutic areas:

Muscular Dystrophy, FacioscapulohumeralFSHD

Worked with same sponsors:

AFM TelethonAMRA Medical+16 more
Collaborated on 2 trials
Similarity Score28%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Amyotrophic Lateral SclerosisALS
Similarity Score9%

Seward Rutkove, MD

Beth Israel Deaconess Medical Center

Related
5 trials

Shared therapeutic areas:

Amyotrophic Lateral SclerosisALS

Worked with same sponsors:

National Institute of Neurological Disorders and Stroke (NINDS)
Similarity Score9%

Steven Levy, MD

MD Stem Cells

Related
5 trials

Shared therapeutic areas:

ALSAmyotrophic Lateral Sclerosis
Similarity Score9%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

ALSAmyotrophic Lateral Sclerosis
Similarity Score9%

loic MONDOLONI

Assistance Publique Hopitaux De Marseille

Related
28 trials

Shared therapeutic areas:

Amyotrophic Lateral Sclerosis
Similarity Score4%

Hamid Gourabi, PhD

head of Royan Institute

Related
52 trials

Shared therapeutic areas:

Amyotrophic Lateral Sclerosis
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (7)

Showing 7 of 7 trials

NCT06847282PrincipalInvestigator

Motor Outcomes to Validate Evaluations in Pediatric FSHD (MOVE Peds)

Muscular Dystrophy, Facioscapulohumeral
Recruiting
NCT06527222Phase 2PrincipalInvestigator

A Study of Ranolazine in ALS

Amyotrophic Lateral Sclerosis
Recruiting
NCT04635891PrincipalInvestigator

Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD)

FSHD
Recruiting
NCT03472950Phase 2PrincipalInvestigator

Safety and Efficacy of Ranolazine for the Treatment of Amyotrophic Lateral Sclerosis

ALS
Completed
NCT03458832PrincipalInvestigator

Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD

Facioscapulohumeral Muscular Dystrophy
Active Not Recruiting
NCT02852278PrincipalInvestigator

A Patient Centric Motor Neuron Disease Activities of Daily Living Scale

Amyotrophic Lateral SclerosisHereditary Spastic ParaplegiaPrimary Lateral Sclerosis+1 more
Completed
NCT02766985PrincipalInvestigator

Rasch-analysis of Clinical Severity in FSHD

Facioscapulohumeral Muscular Dystrophy
Completed

All 7 trials loaded